A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle Arrest
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Link
https://link.springer.com/content/pdf/10.1007/s40266-022-01005-1.pdf
Reference61 articles.
1. Quoix E. Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer. Drugs Aging. 2011;28(11):885–94. https://doi.org/10.2165/11595100-000000000-00000.
2. Falandry C, Krakowski I, Curé H, et al. Granulocyte-colony-stimulating factor in elderly patients receiving chemotherapy for breast and gynaecological cancers: results of a French survey. Anticancer Res. 2014;34(9):5007–15.
3. Dhillon S. Trilaciclib: first approval. Drugs. 2021;81(7):867–74. https://doi.org/10.1007/s40265-021-01508-y(this article explains the mechanism of action of trilaciclib and the potential limitation of its use)
4. Andric Z, Ceric T, Turic M, et al. A phase I B study of the dual MDMX/MDM2 inhibitor for prevention of chemotherapy induced myelosuppression. Presented at the virtual European Society of Medical Oncology Congress September 16 2021 #1654 AP. Ann Oncol. 2021;32(Suppl_5):S1164–74. https://doi.org/10.1016/annonc/annonc68
5. Kirshner JJ, McDonald MC 3rd, Kruter K, et al. NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim. Support Care Cancer. 2018;26(4):1323–34. https://doi.org/10.1007/s00520-017-3959-2. (Epub 2017 Nov 16).
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma;Holistic Integrative Oncology;2024-05-28
2. New Chalcogen-Functionalized Naphthoquinones: Design, Synthesis, and Evaluation, In Vitro and In Silico, against Squamous Cell Carcinoma;ACS Omega;2024-05-08
3. Senotherapy, cancer, and aging;Journal of Geriatric Oncology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3